Survey Data Confirms Manufacturer Priorities for 2024
Each year, the Patient Services Survey gathers insights from pharmaceutical decision-makers, healthcare providers (HCPs), and industry consultants....
Shift the focus to improving patient experience, care, and practice success
Empower your practice to focus on patient care with streamlined administrative solutions
Get in touch with our team for provider client support
Ensure patients can start and stay on the therapies they need by removing obstacles at every step of their journey
Solution
Resources
Our focus has been deeply rooted in one common theme from the beginning — that patients are the priority
Keep up to date on news and announcements at CareMetx
Join our team
Meet with us
It’s a surprisingly common misconception that the patient experience relating to initiating specialty treatments is straightforward once a prescription has been ordered, and once approval has been received from the payer. The truth is, the hurdles patients must overcome to access and adhere to specialty medication are numerous and ongoing.
In the following session, “The Future Hub: Data-driven, Patient-focused," I want to help manufacturers:
As discussed, CareMetx’s data-driven, patient-focused Digital Hub provides things like empathetic, educational and empowering support for patients, and one single point of contact- among other helpful foundational shifts.
The CareMetx Digital Hub also dramatically streamlines fulfillment times (between Rx and first administration) and allows clinicians to better prepare, set expectations and educate patients. This change in focus and level of service is evident to patients, who not only encounter fewer barriers, but are able to get critical help expeditiously when barriers do arise.
Each year, the Patient Services Survey gathers insights from pharmaceutical decision-makers, healthcare providers (HCPs), and industry consultants....
The success of specialty therapeutics often hinges on navigating a complex, multi-step process to initiate patients on a new therapy. Without...
Affordability remains a major challenge for patients prescribed specialty therapy, as costs for these medications continue to climb. Though patient...